The excessive or absent expression of FABP4 has been demonstrated to play a role in various aspects of metabolic disorders and resulting negative consequences, including dyslipidemia, obesity, metabolic syndrome and atherosclerosis [24, 25, 26]. Here, FABP4 is linked to metabolic syndrome.